The latest update is out from Vor Biopharma ( (VOR) ).

Vor Bio is the latest cell therapy company to reach the end of the road. The biotech is immediately winding down clinical and manufacturing operations and laying off almost all staff. Around 95% of ...

Vor Biopharma (VOR) trading was halted on September 18, 2025, pending any announcements from the company. The stock fell over ...

Vor Biopharma, a cancer cell therapy developer that laid off nearly all of its employees in a wind down of operations last month, has reemerged with new management, an in-licensed lead drug candidate, ...

Vor Bio has handed Dallan Murray a swift return to the workforce. Weeks after being let go by Sarepta Therapeutics, Murray has landed the chief commercial officer post in Vor’s new-look C-suite.

VOR (Very High Frequency Omni-Directional Range) stations are ground-based navigation aids that use radio signals to guide aircraft, serving as a backup to GPS. While many VORs are being ...

Using the 2 Stage Free Cash Flow to Equity, Vor Biopharma fair value estimate is US$0.31 With US$0.32 share price, Vor Biopharma appears to be trading close to its estimated fair value Analyst price ...

Telitacicept could generate $1.8 billion in U.S. sales if it captures 15% of the gMG market at $225K per patient. Vor will pay $125 million upfront to RemeGen, with milestone payments exceeding $4 ...

Vor Biopharma on Wednesday said a late-stage study run in China by its partner RemeGen succeeded, showing that treatment with an experimental drug called telitacicept helped reduce disease activity in ...

load I tested for this F&S Bullet Lab is, as the name indicates, loaded with latter. In many rifles, these bullets shoot just as well as match bullets. And finally, these bullets contain no lead. Not ...

A shooter who doesn’t handload is like the guy who is invited on a date by Ms. Elisha Cuthbert and says, “Thanks, but I’d planned to watch MMA reruns tonight.” In other words, you’re missing out on ...

EDT Vor Bio (VOR)pharma trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...